Rhumbline Advisers Has $504,000 Stock Position in Akebia Therapeutics, Inc. (NASDAQ:AKBA)
Rhumbline Advisers grew its stake in Akebia Therapeutics, Inc. (NASDAQ:AKBA – Free Report) by 9.3% during the fourth quarter, HoldingsChannel.com reports. The firm owned 265,389 shares of the biopharmaceutical company’s stock after buying an additional 22,513 shares during the period. Rhumbline Advisers’ holdings in Akebia Therapeutics were worth $504,000 at the end of the most […]
Rhumbline Advisers grew its stake in Akebia Therapeutics, Inc. (NASDAQ:AKBA – Free Report) by 9.3% during the fourth quarter, HoldingsChannel.com reports. The firm owned 265,389 shares of the biopharmaceutical company’s stock after buying an additional 22,513 shares during the period. Rhumbline Advisers’ holdings in Akebia Therapeutics were worth $504,000 at the end of the most […]
